ストックスクリーナーアプリを入手
0.7572
11.45%
0.0778
アフターアワーズ：
.77
0.0128
+1.69%
前日終値:
$0.6794
開ける：
$0.68
24時間の取引高:
1.50M
Relative Volume:
3.00
時価総額：
$33.56M
収益：
$3.82M
当期純損益:
$-51.89M
株価収益率:
-0.5962
EPS:
-1.27
ネットキャッシュフロー:
$-39.52M
1週間 パフォーマンス:
+58.01%
1か月 パフォーマンス:
+4.80%
6か月 パフォーマンス:
-59.94%
1年 パフォーマンス:
-67.08%
1日の値動き範囲:
$0.68
$0.77
1週間の範囲:
$0.45
$0.77
52週間の値動き範囲:
$0.45
$3.2491
Cue Biopharma Inc Stock (CUE) Company Profile
Cue Biopharma Inc Stock (CUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-06-26 | 再開されました | Oppenheimer | Outperform |
| 2022-11-21 | 開始されました | Piper Sandler | Overweight |
| 2022-01-13 | 開始されました | H.C. Wainwright | Buy |
| 2022-01-03 | 開始されました | Craig Hallum | Buy |
| 2020-11-24 | 開始されました | Berenberg | Buy |
| 2020-04-09 | 開始されました | Stifel | Buy |
| 2020-01-28 | 開始されました | BTIG Research | Buy |
| 2020-01-22 | 開始されました | JMP Securities | Mkt Outperform |
すべてを表示
Cue Biopharma Inc (CUE) 最新ニュース
What to expect from Cue Biopharma Inc’s (CUE) current quarter earnings? - US Post News
Cue Biopharma Inc (CUE) Stock: A Year of Highs and Lows - The InvestChronicle
Form 424B5 Cue Biopharma, Inc. - StreetInsider.com
Wall Street SWOT: Cue Biopharma stock pivots to autoimmune focus amid restructuring - Investing.com
Cue Biopharma prices $12M stock offering - MSN
Cue Biopharma Announces Pricing of $12.0 Million Public Offering - StockTitan
Cue Biopharma Announces Pricing of $12.0 Million Public Offering - GlobeNewswire
Cue Biopharma Announces Proposed Public Offering - The Bakersfield Californian
Cue Biopharma Announces Proposed Public Offering - GlobeNewswire
Cue Biopharma launches public stock offering By Investing.com - Investing.com Australia
Cue biopharma announces proposed public offering - MSN
Cue Biopharma Announces Proposed Public Offering - StockTitan
Universal Music Group establishes new division in China’s Greater Bay Area, led by Gary Chan - Music Business Worldwide
Universal Music China Greater Bay Area launches to 'drive forward Chinese pop' - Music Week
UMG Muscles Into Hong Kong and Macau with ‘Universal Music China Greater Bay Area (UMCGBA)’ - Digital Music News
UNIVERSAL MUSIC GROUP LAUNCHES UNIVERSAL MUSIC CHINA GREATER BAY AREA - PR Newswire
Reason why UXIN stock surged today and could keep going - Journal Transcript
Cue Biopharma stock plunges to 52-week low of $0.53 By Investing.com - Investing.com Australia
Cue Biopharma stock plunges to 52-week low of $0.53 By Investing.com - Investing.com South Africa
Cue Biopharma stock plunges to 52-week low of $0.53 By Investing.com - Investing.com Canada
Cue Biopharma stock plunges to 52-week low of $0.53 - Investing.com
Cue Biopharma stock plunges to 52-week low of $0.53 - Investing.com India
Cue Biopharma names J&J vet Lucinda Warren as CBO - The Pharma Letter
Cue Biopharma names Lucinda Warren as new chief business officer - Investing.com
Cue Biopharma names Lucinda Warren as new chief business officer - Investing.com India
Cue Biopharma names Lucinda Warren as new chief business officer By Investing.com - Investing.com Canada
Cue Biopharma names Lucinda Warren as new chief business officer By Investing.com - Investing.com UK
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer - GlobeNewswire
Cue Biopharma Appoints Industry Veteran Lucinda Warren as Chief Business Officer - GlobeNewswire Inc.
Cue Biopharma stock plunges to 52-week low at $0.58 amid market challenges - Investing.com
Cue Biopharma stock plunges to 52-week low at $0.58 amid market challenges - Investing.com India
Cue Biopharma announces director Michael J. Fox's resignation - Investing.com
Cue Biopharma announces director Michael J. Fox's resignation - Investing.com India
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference - GlobeNewswire
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference - StockTitan
Cue Biopharma Inc (CUE) Stock: Exploring a Year of Highs, Lows, and Trading Volume - The InvestChronicle
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates - MSN
Stifel lowers Cue Biopharma shares target amid new strategy and funding needs - Investing.com Canada
Piper Sandler maintains confidence in Cue Biopharma stock as CUE-401 advances - Investing.com Canada
Q2 2024 Cue Biopharma Inc Earnings Call - Yahoo Finance
Cue Biopharma, Inc. (NASDAQ:CUE) Q2 2024 Earnings Call Transcript - Insider Monkey
CUE (Cue Biopharma) Volatility : 52.63% (As of Aug. 20, 2024) - GuruFocus.com
Cue Biopharma Inc (CUE) Q2 2024 Earnings Call Transcript Highlig - GuruFocus.com
Q2 2024 Cue Biopharma Inc Earnings Call Transcript - GuruFocus.com
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewswire
CUECue Biopharma, Inc. Latest Stock News & Market Updates - StockTitan
Cue Biopharma, Inc. (NASDAQ:CUE) Q2 2024 Earnings Call Transcript - MSN
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - ForexTV.com
Cue Biopharma Reports Second Quarter 2024 Financial Results and Recent Business Highlights - StockTitan
Cue Biopharma (STU:1UC) Total Inventories : €0.00 Mil (As of Jun. 2024) - GuruFocus.com
Cue Biopharma (STU:1UC) 3-Year FCF Growth Rate : 8.90% (As of Jun. 2024) - GuruFocus.com
Cue Biopharma Inc (CUE) 財務データ
収益
当期純利益
現金流量
EPS
0.05%
4.86%
大文字化:
|
ボリューム (24 時間):